Placental syndecan expression is altered in human idiopathic fetal growth restriction

American Journal of Pathology

Volumn 180, Issue 2, 2012, Pages 693-702

  Chui, Amy ^a,b   Zainuddin, Nurul ^a,b   Rajaraman, Gayathri ^a,b   Murthi, Padma ^a,b   Brennecke, Shaun P ^a,b   Ignjatovic, Vera ^b   Monagle, Paul T ^b   Said, Joanne M ^a,b  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SYNDECAN 1; SYNDECAN 2; SYNDECAN 3; SYNDECAN 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; MALE; PLACENTA; PLACENTA DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THROMBOSIS;

ADULT; CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; MALE; PLACENTA; PLACENTAL CIRCULATION; PREGNANCY; PROSPECTIVE STUDIES; RNA, MESSENGER; SYNDECAN-1; SYNDECAN-2; SYNDECAN-3; SYNDECAN-4;

EID: 84855988324     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.10.023     Document Type: Article

References (50)

1. B. Brenner Haemostatic changes in pregnancy Thromb Res 114 2004 409 414
2. M.A. Delorme, R.F. Burrows, F.A. Ofosu, M. Andrew Thrombin regulation in mother and fetus during pregnancy Semin Thromb Hemost 18 1992 81 90
3. N. Lanir, A. Aharon, B. Brenner Haemostatic mechanisms in human placenta Best Pract Res Clin Haematol 16 2003 183 195
4. M. Mongelli, J. Gardosi Fetal growth Curr Opin Obstet Gynecol 12 2000 111 115
5. D.D. McIntire, S.L. Bloom, B.M. Casey, K.J. Leveno Birth weight in relation to morbidity and mortality among newborn infants N Engl J Med 340 1999 1234 1238
6. M.S. Kramer, M. Olivier, F.H. McLean, D.M. Willis, R.H. Usher Impact of intrauterine growth retardation and body proportionality on fetal and neonatal outcome Pediatrics 86 1990 707 713
7. J.F. Froen, J.O. Gardosi, A. Thurmann, A. Francis, B. Stray-Pedersen Restricted fetal growth in sudden intrauterine unexplained death Acta Obstet Gynecol Scand 83 2004 801 807
8. I.M. Rosso, T.D. Cannon, T. Huttunen, M.O. Huttunen, J. Lonnqvist, T.L. Gasperoni Obstetric risk factors for early-onset schizophrenia in a Finnish birth cohort Am J Psychiatry 157 2000 801 807
9. K.M. Godfrey, D.J. Barker Fetal nutrition and adult disease Am J Clin Nutr 71 2000 1344S 1352S
10. K.M. Godfrey, D.J. Barker Fetal programming and adult health Public Health Nutr 4 2001 611 624
11. A. Ghidini Idiopathic fetal growth restriction: a pathophysiologic approach Obstet Gynecol Surv 51 1996 376 382
12. C.M. Salafia, J.C. Pezzullo, V.K. Minior, M.Y. Divon Placental pathology of absent and reversed end-diastolic flow in growth-restricted fetuses Obstet Gynecol 90 1997 830 836
13. E. Volante, D. Gramellini, S. Moretti, C. Kaihura, G. Bevilacqua Alteration of the amniotic fluid and neonatal outcome Acta Biomed 75 Suppl 1 2004 71 75
14. T. Vik, T. Markestad, G. Ahlsten, M. Gebre-Medhin, G. Jacobsen, H.J. Hoffman, L.S. Bakketeig Body proportions and early neonatal morbidity in small-for-gestational-age infants of successive births Acta Obstet Gynecol Scand Suppl 165 1997 76 81
15. M. Sugimura, R. Ohashi, T. Kobayashi, N. Kanayama Intraplacental coagulation in intrauterine growth restriction: cause or result? Semin Thromb Hemost 27 2001 107 113
16. J.C. Kingdom, P. Kaufmann Oxygen and placental villous development: origins of fetal hypoxia Placenta 18 1997 613 623
17. C.M. Salafia, L.M. Ernst, J.C. Pezzullo, E.J. Wolf, T.S. Rosenkrantz, A.M. Vintzileos The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth Am J Perinatol 12 1995 106 110
18. M. Uszynski Generation of thrombin in blood plasma of non-pregnant and pregnant women studied through concentration of thrombin-antithrombin III complexes Eur J Obstet Gynecol Reprod Biol 75 1997 127 131
19. M.A. Delorme, L. Xu, L. Berry, L. Mitchell, M. Andrew Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placenta Thromb Res 90 1998 147 153
20. N. Lanir, A. Aharon, B. Brenner Procoagulant and anticoagulant mechanisms in human placenta Semin Thromb Hemost 29 2003 175 184
21. K. Ishiguro, K. Kadomatsu, T. Kojima, H. Muramatsu, E. Nakamura, M. Ito, T. Nagasaka, H. Kobayashi, K. Kusugami, H. Saito, T. Muramatsu Syndecan-4 deficiency impairs the fetal vessels in the placental labyrinth Dev Dyn 219 2000 539 544
22. D.J. Carey Syndecans: multifunctional cell-surface co-receptors Biochem J 327 Pt 1 1997 1 16
23. R. Volk, J.J. Schwartz, J. Li, R.D. Rosenberg, M. Simons The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction J Biol Chem 274 1999 24417 24424
24. K. Elenius, A. Maatta, M. Salmivirta, M. Jalkanen Growth factors induce 3T3 cells to express bFGF-binding syndecan J Biol Chem 267 1992 6435 6441
25. V. Jokimaa, P. Inki, H. Kujari, O. Hirvonen, E. Ekholm, L. Anttila Expression of syndecan-1 in human placenta and decidua Placenta 19 1998 157 163
26. T. Kojima, A. Katsumi, T. Yamazaki, T. Muramatsu, T. Nagasaka, K. Ohsumi, H. Saito Human ryudocan from endothelium-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor J Biol Chem 271 1996 5914 5920
27. T. Kojima, N.W. Shworak, R.D. Rosenberg Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line J Biol Chem 267 1992 4870 4877
28. M.L. Fitzgerald, Z. Wang, P.W. Park, G. Murphy, M. Bernfield Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase J Cell Biol 148 2000 811 824
29. C. Crescimanno, D. Marzioni, F.J. Paradinas, B. Schrurs, J. Muhlhauser, T. Todros, E. Newlands, G. David, M. Castellucci Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast J Pathol 189 1999 600 608
30. A.N. Alexopoulou, H.A. Multhaupt, J.R. Couchman Syndecans in wound healing, inflammation and vascular biology Int J Biochem Cell Biol 39 2007 505 528
31. A. Hienola, S. Tumova, E. Kulesskiy, H. Rauvala N-syndecan deficiency impairs neural migration in brain J Cell Biol 174 2006 569 580
32. M. Kato, S. Saunders, H. Nguyen, M. Bernfield Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells Mol Biol Cell 6 1995 559 576
33. R.L. Guaran, P. Wein, M. Sheedy, J. Walstab, N.A. Beischer Update of growth percentiles for infants born in an Australian population Aust N Z J Obstet Gynaecol 34 1994 39 50
34. P. Murthi, J.M. Said, V.L. Doherty, S. Donath, C.J. Nowell, S.P. Brennecke, B. Kalionis Homeobox gene DLX4 expression is increased in idiopathic human fetal growth restriction Mol Hum Reprod 12 2006 763 769
35. P. Murthi, V. Doherty, J. Said, S. Donath, S.P. Brennecke, B. Kalionis Homeobox gene HLX1 expression is decreased in idiopathic human fetal growth restriction Am J Pathol 168 2006 511 518
36. K.J. Livak, T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
37. P. Murthi, F.A. Faisal, G. Rajaraman, J. Stevenson, V. Ignjatovic, P.T. Monagle, S.P. Brennecke, J.M. Said Placental biglycan expression is decreased in human idiopathic fetal growth restriction Placenta 31 2010 712 717
38. B.C. Swan, P. Murthi, G. Rajaraman, N.A. Pathirage, J.M. Said, V. Ignjatovic, P.T. Monagle, S.P. Brennecke Decorin expression is decreased in human idiopathic fetal growth restriction Reprod Fertil Dev 22 2010 949 955
39. M. Bernfield, R.D. Sanderson Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors Philos Trans R Soc Lond B Biol Sci 327 1990 171 186
40. S. Biswas, S.K. Ghosh Gross morphological changes of placentas associated with intrauterine growth restriction of fetuses: a case control study Early Hum Dev 84 2008 357 362
41. G. Mertens, J.J. Cassiman, H. Van den Berghe, J. Vermylen, G. David Cell surface heparan sulfate proteoglycans from human vascular endothelial cells: core protein characterization and antithrombin III binding properties J Biol Chem 267 1992 20435 20443
42. W.F. Novotny, M. Palmier, T.C. Wun, G.J. Broze Jr, J.P. Miletich Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor Blood 78 1991 394 400
43. L. Wasserman, H. Shlesinger, A. Abramovici, J.A. Goldman, D. Allalouf Changes in glycosaminoglycan composition of normal human placentas with maturation Am J Obstet Gynecol 138 1980 763 768
44. O. Noguer, J. Villena, J. Lorita, S. Vilaro, M. Reina Syndecan-2 downregulation impairs angiogenesis in human microvascular endothelial cells Exp Cell Res 315 2009 795 808
45. L. Jakobsson, J. Kreuger, K. Holmborn, L. Lundin, I. Eriksson, L. Kjellen, L. Claesson-Welsh Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis Dev Cell 10 2006 625 634
46. H. Gitay-Goren, S. Soker, I. Vlodavsky, G. Neufeld The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules J Biol Chem 267 1992 6093 6098
47. S. Sankaran, P.M. Kyle Aetiology and pathogenesis of IUGR Best Pract Res Clin Obstet Gynaecol 23 2009 765 777
48. C.M. Salafia, V.K. Minior, J.C. Pezzullo, E.J. Popek, T.S. Rosenkrantz, A.M. Vintzileos Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features Am J Obstet Gynecol 173 1995 1049 1057
49. S.V. Subramanian, M.L. Fitzgerald, M. Bernfield Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation J Biol Chem 272 1997 14713 14720
50. J.R. Couchman, A. Woods Syndecan-4 and integrins: combinatorial signaling in cell adhesion J Cell Sci 112 Pt 20 1999 3415 3420